![20-F 1 a19-9811_120f.htm 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES ... 20-F 1 a19-9811_120f.htm 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES ...](https://www.sec.gov/Archives/edgar/data/839923/000110465919034465/g98111be01i001.jpg)
20-F 1 a19-9811_120f.htm 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES ...
Jonathan Davitte - Director, Observational Data (Human Genetics) / R&D Esprit Associate - GSK | LinkedIn
![IJERPH | Free Full-Text | New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union | HTML IJERPH | Free Full-Text | New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union | HTML](https://www.mdpi.com/ijerph/ijerph-17-08704/article_deploy/html/images/ijerph-17-08704-g001.png)